Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Budget Health Benefits topic
No spam. Unsubscribe anytime.
Consultant warns of 2026 health-benefit volatility; district says self-insured position helps but monitors reserves
Summary
Integrity Consulting Group presented health-benefit trends including higher utilization, more high-cost claims and rising pharmacy costs driven by GLP-1 drugs; the district said being self-insured places it in a comparatively stronger position but warned of monthly claim pressure and reliance on reserves.
Robert Maguire of Integrity Consulting briefed the board on health-benefit trends that will shape the district’s 2026 budget. He said the marketplace shows increased utilization as patients catch up on delayed care following the COVID period, a doubling in the number of members generating very high claims in some large groups, rising out-of-network claim costs and consolidation among providers.
Maguire highlighted rapid growth in GLP-1 weight-loss medications (brand examples named during the presentation) and said those drugs are now a meaningful share of pharmacy spend. He cited marketplace estimates and state plan adjustments, and noted New Jersey’s state educators plan showed large proposed increases this year; the district itself is self-insured and therefore conducts annual marketplace surveys beginning in January.
Administrators explained the district has reserve funds (IBNR and marketplace reserve) to cover claim runoff and that recent years ran near or under budget; this year early indicators show elevated claims with staff mentioning a run rate nearing $2,000,000 per month for health benefit costs. The board discussed the limits imposed by Chapter 44 (state law affecting educator-plan enrollment and bargaining options for new hires) and the inability of districts to unilaterally change some plan design elements until state-level policy changes are made.
Board members asked when deferred-care cost spikes might stabilize; the consultant said some stabilization is likely over time as delayed care is completed, but expressed concern over the potential for further spikes as new formulations (including oral forms) of GLP-1 drugs become available.
Budget implication: administrators said the district remains self-insured and is monitoring marketplace quotes, reserves and quarterly prescription rebates; they plan to take market proposals in January and incorporate updated trend assumptions into the 2026 budget process.
